![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 37, 34567-34572, September 14, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry, University of Texas Health
Science Center, San Antonio, Texas 78229-3900
Received for publication, June 29, 2001, and in revised form, July 9, 2001
Gap junctions are important in maintaining lens
transparency and metabolic homeostasis. In this paper, we report that
the gap junction-forming protein, connexin (Cx) 45.6, was specifically truncated during lens development and that the majority of the truncated fragments were located in the differentiated lens fibers. When isolated lens membranes were treated by caspase-3, the truncated fragments of Cx45.6 were reproduced, and this truncation occurred at
the COOH terminus of Cx45.6. Moreover, when primary lens cells were
treated with apoptosis-inducing reagents, Cx45.6 was cleaved similarly
as the in vitro treatment by caspase-3, and this cleavage was blocked by a caspase-3 inhibitor. These results suggest that caspase-3 is responsible for the development-associated cleavage of
Cx45.6. The cleavage site of Cx45.6 was identified between amino acid
residues Glu367 and Gly368. We have shown
previously that Ser363 is an in vivo
phosphorylated site by casein kinase II, and this specific
phosphorylation leads to a rapid turnover of Cx45.6. Interestingly, we
found here that when Ser363 was phosphorylated by casein
kinase II, the cleavage of Cx45.6 catalyzed by caspase-3 was inhibited.
This study, for the first time, demonstrates that a connexin can be a
direct target of an apoptotic protease and that cleavage by
caspase-3-like protease leads to the development-associated truncation
of a lens connexin. Finally, caspase-3-mediated cleavage can be
regulated by casein kinase II-mediated phosphorylation, suggesting that
Cx45.6 turnover and specific cleavage by caspase-3-like protease is
alternatively modulated.
The vertebrate lens is one of the most important model systems
used in the study of the function and regulation of gap junctions. The
lens is an avascular organ composed of an anterior epithelial cell
layer and highly differentiated fibers ranging from the outer cortex
toward the central core region. The terminal differentiation and aging
of lens fibers are marked by dramatic morphological changes. As new
cells arise on the outside of the lens, older cells are pushed inward
where nuclei and organelles are lost (1). Because these cells are never
lost from the lens, the most central cells are as old as the organism
itself. The survival of lens cells relies on the intercellular
communications between these cells and the cells at the lens surface
through a large network of gap junctions that facilitate the exchange
of ions and metabolites throughout the organ (2, 3).
Gap junctions are intercellular channels between two adjacent cells,
which allow passage of small molecules ( Differentiating lens fibers share a number of morphological and
biochemical characteristics with cells undergoing apoptosis such as
nucleus degeneration, loss of organelles, and activation of members of
a cysteine protease family named caspase (18-21). However, unlike
apoptotic cells, which are rapidly digested, the organelle-free lens
fibers retain their basic cell integrity and metabolism throughout the
lifetime of the organ. Poly(ADP-ribose) polymerase, an enzyme involved
in DNA repair and maintenance of genomic integrity, is cleaved by
caspases in the developing lens (18). Caspase-3 is predominantly
activated during staurosporine-induced apoptosis in lens cells (22).
The function of caspases has been reported to be responsible for
nucleus degradation during the later stage of lens fiber
differentiation (18). Although activation of caspases has been
demonstrated during lens fiber differentiation, only a couple of
caspase substrates have been identified, such as cytoskeletal proteins
named Connexin (Cx)1 45.6 is one of
the connexins expressed in chick lens fibers (23, 24). Cx45.6, which is
different from the other two chick lens connexins, Cx43 and Cx56, seems
to be involved in lens development and differentiation. Mutations in
Cx50, the mammalian ortholog of Cx45.6, have been identified in human
cataract families (25, 26). Mice deficient in Cx50 not only develop cataracts, but also exhibit microphthalmia with a decrease of lens size
(27). Primary cultures of chick lens closely mimic in vivo
lens cell differentiation processes in which the monolayer of the lens
epithelial cells differentiate into structures called "lentoids"
displaying features of differentiated lens fibers (28, 29). We have
recently shown that overexpression of Cx45.6 in lens primary cultures
stimulates lens cell differentiation and formation of fibers (30).
Additionally, Cx45.6 is subjected to post-translational modification
in vivo. Cx45.6 is a phosphoprotein (23, 31). We have
recently shown that Cx45.6 is phosphorylated in vivo by CKII
at Ser363 located at the COOH-terminal region, and this
phosphorylation facilitated the turnover of Cx45.6 (17). A previous
report shows that Cx50, the ovine ortholog of Cx45.6, is also truncated
at the COOH terminus in the center of the lens by a protease called calpain (32).
Although post-translational modifications, such as phosphorylation and
specific truncation of lens connexins, have been investigated previously, the physiological significance and regulatory mechanism of
these modifications in lens differentiation and development are less
certain. In this report, we identified a specific proteolytic cleavage
of Cx45.6 associated with lens development. Our experimental evidence
suggests that the protease involved in this cleavage is
caspase-3, an apoptotic protease. Moreover, the cleavage site by
caspase-3 in Cx45.6 was identified to be close to the phosphorylated site by CKII. This specific phosphorylation protects Cx45.6 from cleavage by caspase-3. This is the first report showing that the apoptotic protease, caspase-3, is responsible for cleavage of a
connexin, and this specific cleavage is regulated by a specific phosphorylation.
Materials--
Fertilized chicken eggs were obtained from SPAFAS
(Roanoke, IL) and Tyson Hatchery (Gonzalez, TX). CKII and
caspase-3 were obtained from Sigma. Caspase-3 inhibitor Z-DEVD-FMK was
from Calbiochem. [ Preparation of GST Fusion Proteins and Immunoaffinity
Purification of Anti-Cx45.6 Antibody--
Bacterial fusion proteins
containing GST fused with various portions of Cx45.6 were prepared as
described (23, 33). The fusion proteins generated included
the following: GST fused with partial COOH terminus of Cx45.6,
GST-Cx45.6F1 (amino acids 307-389) and its corresponding site mutants,
GST-Cx45.6F1(D364A) and GST-Cx45.6F1(E367A); GST fused with entire COOH
terminus of Cx45.6, GST-Cx45.6F2 (amino acids 237-400); and GST fused
with intracellular loop region of Cx45.6, GST-Cx45.6(L) (amino acids
98-148). Briefly, DNA fragments containing various portions of Cx45.6
or its mutants were produced by PCR with specific oligonucleotide
primers. The codon GAT encoding Asp364 was changed to GCT
encoding Ala and GAA encoding Glu367 was altered to GCA
encoding Ala in one of the two primer sequences required for mutant
synthesis. Each DNA fragment generated was inserted into the expression
vector pGEX-2T. The recombinant fusion proteins were expressed in
Escherichia coli, induced by
isopropyl-thio- SDS-PAGE and Western Blotting--
The fusion proteins and crude
membrane samples were loaded in each lane of a 10% SDS-PAGE. For
Western blotting, samples on SDS-PAGE were transferred to
nitrocellulose membranes according to the method of White et
al. (34). Membranes were probed with the affinity-purified
preimmune or Cx45.6 antibody (1:500 dilution). The primary antibodies
were detected either with alkaline phosphatase-conjugated secondary
anti-rabbit antiserum or peroxidase-conjugated secondary anti-rabbit
antiserum and followed by chemiluminescence reagent kit (ECL) (Amersham
Pharmacia Biotech) according to the manufacturer's instruction. The
membranes were exposed to X-Omat AR films (Eastman Kodak) and detected
by fluorography.
Preparation of Retroviral Constructs and High Titer Retroviruses
Containing Wild Type and Mutant Cx45.6--
Retroviral constructs and
high titer viruses were prepared based on our protocol described
previously (35). Briefly, cDNA fragment containing the wild type
Cx45.6 was made by PCR and was constructed into the retroviral vector
RCAS(A) as described (17, 36). With the wild type RCAS(A)-Cx45.6 DNA
construct as a template, retroviral constructs of Cx45.6 mutants
containing point mutations were generated with the
QuikChangeTM Site-directed Mutagenesis kit according to the
manufacturer's instructions. The codon alteration for site mutants,
RCAS(A)-Cx45.6(D364A) and RCAS(A)-Cx45.6(E367A), were described above.
RCAS(A)-Cx45.6(E367D) was made by changing codon GAA encoding
Glu367 to GAT encoding Asp. All constructs generated were
sequenced at the Institutional DNA Sequencing Facility. The high titer
retroviruses (1-5 × 108 colony forming units/ml)
containing the wild type and the mutant RCAS(A) Cx45.6 constructs were
prepared as we have described previously (35, 36).
Isolation of Cell Membranes from Lens or CEF Cells
and in Vitro Cleavage by Caspase-3--
The crude cell membranes were
isolated and prepared as described (37). Briefly, lenses from embryonic
day 9 or CEF cells infected with retroviruses were lysed in lysis
buffer (5 mM Tris, pH 8.0, and 5 mM EDTA/EGTA)
plus 2 mM phenylmethylsulfonyl fluoride, 10 mM
N-ethylmaleimide, and 100 µM leupeptin. Crude membranes were pelleted at 35,000 rpm for 30 min (Beckman SW60 rotor).
The crude membranes from CEF cells and lenses or the purified GST
fusion proteins were subjected to in vitro cleavage by
caspase-3. Crude membranes or 2.5 µg of various GST fusion proteins
were incubated at 37 °C in 25 µl of caspase-3 reaction buffer (50 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5 mM sucrose, and 5% glycerol) with and without 0.3 µg of
caspase-3 at various times. Reactions were terminated by the addition
of electrophoresis sample buffer (50 mM Tris, pH 6.8, 1%
SDS, 2% Preparation of Primary Lens Cultures, Treatment with
Apoptosis-inducing Reagents, and Inhibition of Caspase-3
Activity--
Primary lens cultures were prepared according to the
procedure described previously (17, 38). Briefly, chick lenses
dissected from embryonic day 11 embryos were ruptured, and the cells
that dissociated from the lenses were plated at 1 × 106 cells per 35-mm tissue culture plates in medium 199 plus 10% fetal bovine serum. Eight days after cell plating, primary
cultures were treated either with 5 µM staurosporine
dissolved in culture medium or with 2 mM EGTA for 4.5 h at 37 °C. When caspase-3 inhibitor Z-DEVD-FMK was used, cultures
were preincubated with this inhibitor for 1 h before exposure to
staurosporine or EGTA.
Culture of CEF Cells, Retroviral Expression, and Treatment with
Apoptosis-inducing Reagents--
CEF cells were plated at 1 × 105 cells in 35-mm tissue culture plates with DMEM plus
10% fetal calf serum and 5% CO2. The 2nd day after cell
plating CEF cells were infected with high titer retroviruses (5 µl/dish) carrying either the wild type or the mutant Cx45.6
cDNAs. When CEF cells reached confluence, they were collected
either for membrane preparation or for treatment with apoptosis-inducing reagents. CEF cells were treated in the
presence of 1 mM staurosporine for 8 h at
37 °C.
Phosphorylation of Cx45.6 by CKII, Radioactive Labeling of Lens
Organ, in Vitro Cleavage by Caspase-3, and
Immunoprecipitation--
The isolated embryonic lens membranes were
incubated in 20 µl of CKII reaction buffer (10 mM
MgCl2, 50 mM MOPS, pH 7.0, 150 mM
NaCl, and 20 µCi of [ Development-associated Cleavage of Lens Cx45.6--
Chick lenses
at embryonic (E) days 8, 12, 15, and 18 and postnatal (P) days 1, 15, 30, and 60 were immunoblotted with affinity-purified Cx45.6 antibody
that recognized the intracellular loop region of Cx45.6. The
full-length Cx45.6 was phosphorylated in vivo and migrated
as three close bands at the positions of 53, 56, and 58 kDa (Fig.
1) as demonstrated previously (23). At
E8, a full-length Cx45.6 was solely present in the lens (Fig. 1,
lane 1). Starting at E12, an additional band appeared
migrating at around 46 kDa (empty arrowhead) (Fig. 1,
lane 2) and its concentration level increased during the
development of the lens as shown at E15 (Fig. 1, lane 3),
E18 (Fig. 1, lane 4), and postnatal stages (Fig. 1, lanes 5-8). In addition, a 48-kDa fragment (solid
arrowhead) closely migrating with the 46-kDa fragment appeared at
E15, which is a lesser amount than 46-kDa fragment at embryonic stages.
The level of this fragment, however, increased dramatically at the
later developmental stages and reached a similar level as the 46-kDa fragment approaching P15 (Fig. 1, lane 6). No protein bands
could be detected using pre-immune antibody (data not shown).
To exclude the possibility that these cleavages may have occurred
during sample preparation, we incubated lysates from embryonic and
postnatal lenses at room temperature for 16 h and did not detect
any accumulation of these fragments (data not shown). To determine if
one of the closely migrated fragments was the phosphorylated form of
another fragment, crude membranes from lens at P30 were treated with
alkaline phosphatase. The levels of these two fragments were not
altered (data not show), suggesting that neither of the fragments is
the phosphorylated form of the other.
The Majority of the Cleaved Fragments Was Identified at the Central
Core Region of the Postnatal Lenses--
The exterior portions of the
2-month postnatal chick lens containing epithelial cells and the fibers
of the outer cortex were separated from the central core portion of the
lens composed of mature lens fibers. The whole lens lysate contained
both the full-length Cx45.6 and the cleaved fragments (Fig.
2, lane 3, arrowheads). However, the cleaved fragments predominantly existed in the mature fibers of the central core (Fig. 2, lane 1, arrowheads) and
to a much lesser extent in the outer cortex which, in contrast, was mainly composed of full-length Cx45.6 (Fig. 2, lane 2).
Because cells are retained in the lens and new cells continually arise on the outside of the lens, most cells in the central core regions are
differentiated mature lens fibers (1). Consistent with the observation
in Fig. 1 that truncated Cx45.6 fragments were accumulated associated
with lens development, the results indicate that the specific cleavage
of Cx45.6 in differentiated lens fibers may be related to the process
of lens cell differentiation and formation of mature fibers.
The Development-associated Cx45.6 Cleavage Was Reproduced in Vitro
by Caspase-3--
To identify the potential protease(s) involved in
the cleavage of Cx45.6 during lens development, we first experimented
with Ca2+-activated, cysteine protease calpain. This
protease cleaves at the COOH terminus of Cx50, the ovine counterpart of
Cx45.6 in the central region of the lens (32). Western blot of the
membranes from embryonic (E) day 9 chick lens revealed a full-length
Cx45.6 (Fig. 3A, lane 2).
Treatment by calpain led to a cleavage from a full-length Cx45.6 into a
major 33-kDa fragment (Fig. 3A, lane 3, open arrowhead),
different from the 46-kDa fragment observed in the 2-month P chick lens
(Fig. 3A, lane 1, solid arrowhead). This result suggests
that unlike ovine Cx50 calpain is unlikely involved in the in
vivo truncation of Cx45.6 in chick lens.
Caspase-3-like protease involved in apoptosis has been reported to be
activated when lens epithelial cells differentiate into fibers in
vivo (39), and caspase-3 expression is localized in the outer
fibers (18). Caspase-3 is activated between embryonic days 8 and 12 in
chick lens (18), which is at the similar time frame as when the
cleavage of Cx45.6 was observed. To determine whether caspase-3 is the
protease responsible for the cleavage, embryonic lens membranes were
incubated with caspase-3. As shown in Fig. 3B, after 2-h
incubation, the full-length Cx45.6 was partially cleaved into fragments
around 46 kDa (Fig. 3B, lane 1, arrowhead), which migrated
to the same position as the truncated Cx45.6 of the lens membrane from
the newborn chick (Fig. 3B, lane 5, arrowhead). After 16-h incubation with caspase-3, the majority of the full-length Cx45.6 proteins was cleaved (Fig. 3B, lane 3, arrowhead).
These results indicate that Cx45.6 may be a direct substrate for
caspase-3. Alternatively, Cx45.6 can be cleaved by other protease(s)
present in the lens membrane that could be activated by caspase-3. To
examine these possibilities further, purified fusion proteins
containing GST fused with portions of Cx45.6 were used for in
vitro caspase-3 enzymatic digestion. The fusion parts of Cx45.6
include the following: the intracellular loop of Cx45.6 (GST-45.6L)
(amino acids 98-148) (Fig. 3C, lanes 3 and 4),
partial COOH terminus (GST-45.6 F1) (amino acids 307-389) (Fig.
3C, lanes 5 and 6), and entire COOH terminus
(GST-45.6F2) (amino acids 237-400) (Fig. 3C, lanes 7 and
8). These fusion proteins, together with the GST protein
itself (Fig. 3C, lanes 1 and 2), were treated with caspase-3. Both GST-45.6 F1 (Fig. 3C, lane 6) and
GST-45.6F2 (Fig. 3C, lane 8) were cleaved by caspase-3
(arrowheads), whereas GST protein (Fig. 3C, lane
2) and GST-45.6L (Fig. 3C, lane 4) were not cleaved.
These results suggest that Cx45.6 is a substrate of caspase-3 and that
the cleavage site is located within the COOH terminus between amino
acids 307 and 389.
Development-associated Truncation of Cx45.6 Was Reproduced by a
Caspase-3-like Protease Following the Treatment of Apoptosis-inducing
Reagents in Lens Cells--
To examine whether Cx45.6 can be cleaved
by caspase-3 in lens cells, primary lens cultures were incubated with
apoptosis-inducing reagents staurosporine (Fig.
4, lane 2) (22) or EGTA (Fig.
4, lane 4) (40). These two compounds are known chemical
inducers for caspase-mediated apoptosis (22, 40). Treatments by both reagents regenerated fragments around 46 kDa (Fig. 4, lanes
2 and 4, arrowhead). The cleavage was significantly
inhibited by Z-DEVD-FMK, a caspase-3 inhibitor (Fig. 4, lane
5). The results confirm that caspase-3 is likely to be involved in
the cleavage of Cx45.6 in vivo.
Caspase-3 Cleaved Cx45.6 between Amino Acid Residues
Glu367 and Gly368--
The amino
acid sequence Asp364-Glu-Val-Glu367-Gly
was identified in the COOH-terminal region of Cx45.6 (see Fig.
5A). This sequence is similar
to a known caspase-3 consensus sequence (41) with the exception of
substituting Asp with Glu at position 367. If cleavage by caspase-3
occurs between Glu367 and Gly368, the predicted
molecular weight of one of the cleaved fragments would match that of
the 46-kDa fragment. The two aspartate residues in the consensus
sequence of caspase-3 are essential, and cleavage cannot occur if
either residue is altered to alanine (42). Since glutamate like
aspartate is an acidic residue, this segment of the sequence in Cx45.6
is a potential target for caspase-3. As illustrated in Fig.
5A, mutants were constructed with alterations in the
conserved amino acid residues corresponding to the consensus sequence
of caspase-3. Fusion proteins GST-Cx45.6F1, and its mutants GST-Cx45.6F1(D364A) and GST-Cx45.6F1(E367A), were subjected to caspase-3 cleavage in vitro (Fig. 5B).
GST-Cx45.6F1 was cleaved by caspase-3 into two closely migrating bands
(Fig. 5B, lane 2). Both GST-Cx45.6F1(D364A) (Fig. 5B,
lane 4) and GST-Cx45.6F1(E367A) (Fig. 5B, lane 6)
exhibited resistance to cleavage by caspase-3. These data suggest that
either Asp364 or Glu367 seems to be crucial in
the cleavage by caspase-3.
The COOH terminus of Cx45.6 in GST fusion protein may not have similar
conformation as compared with the one in the membrane-spanning full-length molecule. Therefore, full-length Cx45.6 and its mutants carrying alterations of conserved residues corresponding to caspase-3 (see Fig. 5A) were expressed in CEF cells through retroviral
infection, and the isolated cell membranes were subjected to caspase-3
treatment (Fig. 5C). Similar to the results shown for fusion
proteins, mutations in D364A and E367A prevented cleavage of Cx45.6 by
caspase-3 (Fig. 5C, lanes 4 and 6). Furthermore,
the mutation of E367D, producing a cleavage sequence in Cx45.6
identical to the consensus sequence for caspase-3, increased cleavage
(Fig. 5C, lane 8). The ratio of the fragments around 46 kDa
to the full-length form of Cx45.6(E367D) (Fig. 5C, lane 8)
is greater than that to the full-length wild type Cx45.6 (Fig.
5C, lane 2).
Similar results were observed when CEF cells expressing wild
type and mutant Cx45.6 were treated by the apoptosis-inducing reagent
staurosporine (Fig. 5D). Neither Cx45.6(D364A) nor
Cx45.6(E367A) was cleaved (Fig. 5D, lanes 4 and
6), whereas the wild type Cx45.6 was (Fig. 5D, lane
2). In comparison to the wild type Cx45.6, the cleavage of
Cx45.6(E367D) was further enhanced (Fig. 5D, lane 8).
Together, the results obtained from fusion proteins and
full-length Cx45.6 expressed in cells suggest that the cleavage site of
Cx45.6 by caspase-3 is between Glu367 and
Gly368.
Inhibition of Caspase-3-catalyzed Cleavage of Cx45.6 by
Phosphorylation of Cx45.6 by CKII--
We have reported that
Ser363, an amino acid residue close to the caspase-3
cleavage site, is phosphorylated in vivo by CKII (17). Phosphorylation of certain substrates has been shown to be important in
regulating their cleavage by caspase-3 (42, 43). To determine whether
phosphorylation at Ser363 affects the ability of Cx45.6 to
serve as a substrate for caspase-3, Cx45.6 in the membranes of
embryonic lenses was treated in the presence of CKII and followed by
proteolytic digestion by caspase-3 (Fig.
6, lane 2). The results
indicate that Cx45.6 phosphorylated by CKII was protected from
caspase-3 digestion. To ensure that Cx45.6 in both full-length and
truncated forms could be immunoprecipitated, embryonic lenses were
metabolically labeled with [35S]methionine and chased in
non-radioactive medium immediately (Fig. 6, lanes 3 and
4) and after 6 h of incubation (Fig. 6, lanes 5 and 6). The isolated membranes labeled with
[35S]methionine were treated in the presence (Fig. 6,
lanes 4 and 6) and absence (Fig. 6, lanes
3 and 5) of caspase-3 and followed by
immunoprecipitation. The Cx45.6 antibody we used here was capable of
immunoprecipitating the full-length as well as the truncated (arrowhead) Cx45.6 cleaved by caspase-3. Together,
the data suggest that the specific cleavage of Cx45.6 by caspase-3 is
likely to be regulated by CKII-mediated phosphorylation.
In this report, we identified caspase-3 as the protease
responsible for the cleavage of Cx45.6 during chick lens development. Additionally, the cleavage on Cx45.6 was localized to the site close to
the amino acid residue phosphorylated by CKII. Our previous studies
(17) have shown that Cx45.6 is phosphorylated in vivo by
CKII at Ser363, and this phosphorylation may be a signal
for Cx45.6 degradation mediated by proteasome. Here, we found that
phosphorylation of Ser363 by CKII protected Cx45.6 from
cleavage by caspase-3, suggesting that the specific cleavage of Cx45.6
is regulated by CKII-mediated phosphorylation.
Based on our experimental evidence, a model is proposed for the
involvement of CKII-mediated phosphorylation in the regulation of
Cx45.6 turnover and specific cleavage by caspase-3-like protease. In
the outer cortex of the lens, when a full-length Cx45.6 is phosphorylated by CKII at Ser363, it becomes unstable and
possibly undergoes degradation mediated through the proteasome pathway
(17). The CKII phosphorylation site Ser363 is located
within a PEST domain (17, 44), and this domain has been reported to be
associated with a rapid protein turnover via proteasome-mediated
degradation (45). Additionally, phosphorylation is also known to signal
protein degradation by proteasome (46). When Ser363 is not
phosphorylated by CKII, Cx45.6 renders itself into a substrate for
caspase-3, which cleaves at Glu367 at the COOH terminus of
Cx45.6 and generates truncated fragments of Cx45.6. These fragments
were localized to the central core region of the lens.
We observed two fragments derived from Cx45.6 in the size of 46 and 48 kDa. These fragments were accumulated during lens development. The
46-kDa fragment was predominant during the embryonic stage, whereas the
level of the 48-kDa fragment increased and reached a similar level as
compared with the 46-kDa form at the postnatal stage. Formation of two
fragments was also observed when GST-Cx45.6F1 was treated with
caspase-3. However, mutation of a potential cleavage site in
GST-Cx45.6F1 blocked the production of either fragment, suggesting that
this site initiates generation of these two fragments. Because of the
closeness of their migration, these two fragments sometimes were less
distinctive on the SDS-PAGE. We also observed a potential third band
larger than 48 kDa at P60 samples, and this band could be generated
from additional cleavage or certain type of posttranslational modifications.
Our data suggest that caspase-3-like protease is responsible for the
in vivo cleavage of Cx45.6. In contrast to our observation in chicken, a previous study has shown that a large portion of the COOH
terminus of Cx50, the ovine ortholog of Cx45.6, is removed by calpain
(32). This discrepancy could account for the difference in expression
level or accessibility of these two proteases expressed in these two
species, because the responsibility of one protease could be replaced
by the other during evolution. It is also likely that the cleaved
fragment of Cx50 observed in ovine is caused by in vitro
experimental manipulation. We found if lysates of lens primary cells
were handled improperly, Cx45.6 would be cleaved into a 33-kDa
fragment, an identical size fragment as the fragment cleaved by calpain
(data not shown).
We have also shown that the truncated Cx45.6 was accumulated during
lens development and was localized to the differentiated lens fibers.
The activation of caspases-3 also initiates in the differentiated lens
fibers and is involved in later stage cell differentiation, such as
nucleus degeneration (18). Thus, the caspase-3-truncated Cx45.6 is
likely to form a unique type of gap junctions, different from the ones
formed by full-length Cx45.6. These intercellular channels may
facilitate the passage of factors important for fiber differentiation
and/or maintain the physiological functions of mature fibers.
Functional gap junction channels are, indeed, formed by truncated Cx50
of ovine lens (32). These channels are characterized to be less
sensitive to low pH, compared with those formed by full-length Cx50.
Studies by Le and Musil (47) have shown that lens primary cultures
differentiate normally even if the channels are blocked with the gap
junction inhibitor 18 Lens Cx45.6 is the first connexin identified as a substrate for
caspase. In addition to lens fibers other cell types, such as skin
keratinocytes, also undergo degeneration of nuclei and organelles
during cell differentiation. Caspase activation has been identified in
the differentiation of epidermal keratinocytes and is required for the
loss of the nucleus (49). It is of great interest to determine whether
connexins in those cells are also subjected to regulation by caspases.
The physiological significance of the regulation of connexins by
caspases requires further investigation.
We thank D. Adan-Rice and L. Wang for
technical assistance and Z. Dong for valuable discussions. We thank
members of the Jiang laboratory for critical reading of the manuscript.
*
This work was supported by National Institutes of Health
Grant EY-12085 (to J. X. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, July 11, 2001, DOI 10.1074/jbc.M106073200
The abbreviations used are:
Cx, connexin;
CKII, casein kinase II;
CEF, chicken embryonic fibroblast;
DMEM, Dulbecco's
modified Eagle's medium;
GST, glutathione S-transferase;
PAGE, polyacrylamide gel electrophoresis;
PCR, polymerase chain
reaction;
Z, benzyloxycarbonyl;
FMK, fluoromethyl ketone;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid;
E, embryonic day;
P, postnatal day.
The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated
Phosphorylation*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1000 Da) such as small
metabolites, ions, and second messengers. The structural components of
gap junctions are the members of a protein family called connexins,
which consist of four conserved transmembrane domains and two
extracellular loops, whereas their cytoplasmic regions are unique. The
COOH terminus, the most variable region among connexins, contains
several kinase and protease consensus sequences. Connexins are highly
dynamic proteins that undergo rapid turnover both in cell lines (4) and
in animal organs (5-7). The degradation has been identified to undergo
either through the lysosome or proteasome pathway (8-12).
Phosphorylation has been demonstrated to play an important role in
regulation of gap junction stability and turnover (13-16). We have
recently shown that an in vivo phosphorylated lens connexin
undergoes a faster turnover than its unphosphorylated counterpart
(17).
- and
-spectrins (21).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP and
[35S]methionine were from PerkinElmer Life Sciences.
Tissue culture reagents were purchased from Life Technologies, Inc.
SDS-PAGE standards were from Bio-Rad. QuikChangeTM
Site-directed Mutagenesis kit was obtained from Stratagene (La Jolla,
CA). Chemiluminescence kit, ECL, was from Amersham Pharmacia Biotech.
X-Omat AR film was obtained from Eastman Kodak.
-D-galactoside, and isolated with GST
beads. To ensure the correct sequence all constructs generated were
sequenced at the Institutional DNA Sequencing Facility. Fusion protein
containing GST plus intracellular loop portion of Cx45.6 was used to
raise polyclonal antisera in rabbits (Pocono Rabbit Farm and Laboratory
Inc, Canadensis, PA). The antisera generated were
immunoaffinity-purified by passage through two Sepharose CL-4B columns,
GST-conjugated and GST-Cx45.6 fusion protein-conjugated, respectively,
as described (23, 33).
-mercaptoethanol, and 35% glycerol) and boiled for 5 min.
-32P]ATP) plus 2 µl of CKII
(119 units/ml) at 30 °C for 2 h. The reaction was stopped by
the inactivation of CKII by incubating at 56 °C for 30 min. Fifty
microliters of caspase-3 reaction buffer were added to the in
vitro phosphorylated lens membrane sample, and the reaction
mixture was then divided into two tubes. In each tube, 3 µl of
caspase-3 or caspase-3 storage buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM dithiothreitol, 1 mM EDTA, 0.1% CHAPS, and 10% (w/v) glycerol) was added
and incubated at 37 °C for 6 h. The reaction was terminated by
boiling the samples for 5 min in the presence of 0.6% SDS prior to the
immunoprecipitation with affinity purified Cx45.6 antibody as
previously described (31, 37). To control for the immunoprecipitation
assay, embryonic day 9 lenses were rinsed three times with culture
medium deficient in methionine prior to the incubation with 1 ml of
35S-labeled medium (methionine-free DMEM with 5% dialyzed
fetal calf serum, 20 µM methionine, and 0.5 mCi of
[35S]methionine) for 3 h. The radioactive medium was
removed, and lenses were incubated in non-radioactive medium (DMEM
supplemented with 0.5 mM methionine and 10% fetal calf
serum) for various chase periods. 35S-Labeled lens
membranes were isolated and treated at the identical condition
as the 32P-labeled sample except the omission of ATP
in CKII reaction mix, followed by the treatment by caspase-3, and
immunoprecipitation as described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (21K):
[in a new window]
Fig. 1.
Specific truncations of Cx45.6 were
associated with lens development. Chick lenses were isolated at E
day 8 (lane 1), 12 (lane 2), 15 (lane
3), and 18 (lane 4) and P day 1 (lane 5), 15 (lane 6), 30 (lane 7), and 60 (lane 8)
and immunoblotted with affinity-purified Cx45.6 antibody, which
recognizes the intracellular loop region of Cx45.6. The truncated
Cx45.6 fragments are indicated by arrowheads.

View larger version (23K):
[in a new window]
Fig. 2.
The majority of the truncated fragments was
identified in the center of postnatal day 60 lenses. The exterior
portions of the lens containing epithelial cells and outer fibers were
separated from the central core region containing mature fibers. Cx45.6
expression in central core (lane 1), epithelia and outer
cortex regions (lane 2), and entire lens lysate (lane
3) was examined by Western blots. The truncated fragments are
shown as arrowheads.

View larger version (23K):
[in a new window]
Fig. 3.
In vitro cleavage of Cx45.6 by
caspase-3. A, in vitro cleavage of Cx45.6 by
calpain. Embryonic day 9 lens membranes were treated in the presence
(lane 3) and absence (lane 2) of calpain at
37 °C for 2 h. The immunoblot with anti-Cx45.6 antibody shows
that calpain cleaved the full-length Cx45.6 into a 33-kDa fragment
(lane 3, indicated by empty arrowhead). This
cleavage was not observed in the 2-month postnatal chick lens
(lane 1), in which the 46-kDa fragments are indicated
(solid arrowhead). B, cleavage of Cx45.6 by
caspase-3 in lens membranes. Embryonic lens membranes were incubated
with and without caspase-3 for 2 (lanes 1 and 2)
and 16 h (lanes 3 and 4) and compared with
Cx45.6 in newborn chick lens membranes (lane 5). The
fragments generated by caspase-3 treatment migrated around 46 kDa,
identical to the in vivo cleaved fragments from newborn
lenses (arrowhead). C, cleavage of GST fusion
proteins containing portions of Cx45.6 by caspase-3. GST protein
(lanes 1 and 2) and GST fusion proteins
containing the intercellular loop (GST-45.6L) (lanes 3 and
4), partial COOH terminus (GST-45.6F1, amino acids 307-389)
(lanes 5 and 6), or entire COOH terminus
(GST-45.6F2, amino acids 237-400) (lanes 7 and
8) were treated in the presence (lanes 2, 4, 6, and 8) and absence (lanes 1, 3, 5, and
7) of caspase-3 at 37 °C for 6 h. The cleaved
fragments are indicated by arrowheads.

View larger version (30K):
[in a new window]
Fig. 4.
The development-related Cx45.6 cleavage was
reproduced following the treatment of apoptotic reagents in lens
primary cultures. The lens primary cultures were treated in the
presence (lane 2) and absence (lane 1) of 5 µM staurosporine (STS) and in the absence
(lane 3) and presence (lane 4) of 2 mM EGTA for 4.5 h. One of the samples was pretreated
with caspase-3 inhibitor Z-DEVD-FMK (lane 5) for 1 h
prior to the treatment by EGTA. The cleaved fragments are indicated (an
arrowhead).

View larger version (22K):
[in a new window]
Fig. 5.
Caspase-3 cleaved Cx45.6 between amino acid
residues Glu367 and Gly368. A,
caspase-3 consensus sequence and its corresponding sequences in Cx45.6
of wild type (WT) and site mutants, Cx45.6(D364A),
Cx45.6(E367A), and Cx45.6(E367D), are illustrated. The cleavage site is
marked by an arrow (B). Fusion protein GST-45.6F1
(lanes 1 and 2) and its mutants,
GST-45.6F1(D364A) (lanes 3 and 4) and
GST-45.6F1(E367A) (lanes 5 and 6), were treated
with (lanes 2, 4, and 6) and without (lanes
1, 3, and 5) caspase-3. The cleaved fragments are
indicated by an arrowhead. C, exogenous
full-length Cx45.6 (lanes 1 and 2) and its
corresponding site mutants, Cx45.6(D364A) (lanes 3 and
4), Cx45.6(E367A) (lanes 5 and 6), and
Cx45.6(E367D) (lanes 7 and 8), were expressed in
CEF cells through retroviral RCAS(A) infection. Crude membranes of
Cx45.6 expressed in CEF cells were treated with (lanes 2, 4, 6, and 8) and without (lanes 1, 3, 5, and
7) caspase-3, and the fragments resulting from digestion
reaction are indicated by an arrowhead. D, CEF
cells expressing wild type and mutant Cx45.6 through retroviral RCAS(A)
infection were treated with (lanes 2, 4, 6, and
8) and without (lanes 1, 3, 5, and 7)
1 mM staurosporine (STS) for 8 h. The
cleaved fragments are indicated (arrowhead).

View larger version (26K):
[in a new window]
Fig. 6.
Phosphorylation of Cx45.6 by CKII inhibited
its cleavage by caspase-3. Crude membranes of embryonic lenses
were phosphorylated by CKII and [
-32P]ATP and followed
by incubation in the presence (lane 2) and absence
(lane 1) of caspase-3. Cx45.6 was immunoprecipitated and
analyzed by SDS-PAGE and autoradiography. The control experiment was
conducted with embryonic lenses labeled with
[35S]methionine for 3 h and chased in
non-radioactive medium for 0 (lanes 3 and 4) and
6 h (lanes 5 and 6). The crude membranes
from [35S]methionine-labeled lenses were incubated in
CKII reaction mix without ATP followed by the treatment with
(lanes 4 and 6) and without (lanes 3 and 5) caspase-3 and immunoprecipitation by Cx45.6 antibody.
The cleaved fragments are indicated by an arrowhead.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glycyrrhetinic acid. Since
18
-glycyrrhetinic acid has been tested for gap junctions formed
solely by full-length connexins (48), the channels consisting of
truncated connexins may not be similarly inhibited by this chemical.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Biochemistry,
University of Texas Health Science Center, 7703 Floyd Curl Dr., San
Antonio, TX 78229-3900. Tel.: 210-567-3796; Fax: 210-567-6595; E-mail:
jiangj@uthscsa.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Rafferty, N.,
and Esson, E.
(1974)
J. Ultrastruct. Res.
46,
239-253
2.
Mathias, R. T.,
and Rae, J. L.
(1989)
in
Cell Interactions and Gap Junctions
(Sperelakis, N.
, and Cole, W. C., eds)
, pp. 29-50, CRC Press, Inc., Boca Raton, FL
3.
Cooper, K.,
Mathias, R. T.,
and Rae, J. L.
(1991)
in
Biophysics of Gap Junction Channels
(Peracchia, C., ed)
, pp. 57-74, CRC Press, Inc., Boca Raton, FL
4.
Musil, L. S.,
Cunningham, B. A.,
Edelman, G. M.,
and Goodenough, D. A.
(1990)
J. Cell Biol.
111,
2077-2088
5.
Dermietzel, R.,
Traub, O.,
Hwang, T. K.,
Beyer, E.,
Bennett, M. V. L.,
Spray, D. C.,
and Willecke, K.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
10148-10152
6.
Beardslee, M. A.,
Laing, J. G.,
Beyer, E. C.,
and Saffitz, J. E.
(1998)
Circ. Res.
83,
629-635
7.
Fallon, R. F.,
and Goodenough, D. A.
(1981)
J. Cell Biol.
90,
521-526
8.
Guan, X. J.,
and Ruch, R. J.
(1996)
Carcinogenesis
17,
1791-1798
9.
Laing, J. G.,
and Beyer, E. C.
(1995)
J. Biol. Chem.
270,
26399-26403
10.
Laing, J. G.,
Tadros, P. N.,
Westphale, E. M.,
and Beyer, E. C.
(1997)
Exp. Cell Res.
236,
482-492
11.
Musil, L. S.,
Le, A.-C. N.,
VanSlyke, J. K.,
and Roberts, L. M.
(2000)
J. Biol. Chem.
275,
25207-25215
12.
Berthoud, V. M.,
Tadros, P. N.,
and Beyer, E. C.
(2000)
Methods
20,
180-187
13.
Hertlein, B.,
Butterweck, A.,
Haubrich, S.,
Willecke, K.,
and Traub, O.
(1998)
J. Membr. Biol.
162,
247-257
14.
Berthoud, V. M.,
Bassnett, S.,
and Beyer, E. C.
(1999)
Exp. Eye Res.
68,
475-484
15.
Hossain, M. Z.,
Ao, P.,
and Boynton, A. L.
(1998)
J. Cell. Physiol.
174,
66-77
16.
Elvira, M.,
Diez, J. A.,
Wang, K. K. W.,
and Villalobo, A.
(1993)
J. Biol. Chem.
268,
14294-14300
17.
Yin, X.,
Jedrzejewski, P. T.,
and Jiang, J. X.
(2000)
J. Biol. Chem.
275,
6850-6856
18.
Wride, M. A.,
Parker, E.,
and Sanders, E. J.
(1999)
Dev. Biol.
213,
142-156
19.
Wride, M. A.
(2000)
Apoptosis
5,
203-209
20.
Dahm, R.
(1999)
Ophthalmic Res.
31,
163-183
21.
Lee, A.,
Morrow, J. S.,
and Fowler, V. M.
(2001)
J. Biol. Chem.
276,
20735-20742
22.
Andersson, M.,
Sjöstrand, J.,
Petersen, A.,
Honarvar, A. K. S.,
and Karlsson, J.
(2000)
Invest. Ophthalmol. Vis. Sci.
41,
2623-2632
23.
Jiang, J. X.,
White, T. W.,
Goodenough, D. A.,
and Paul, D. L.
(1994)
Mol. Biol. Cell
5,
363-373
24.
Jiang, J. X.,
White, T. W.,
and Goodenough, D. A.
(1995)
Dev. Biol.
168,
649-661
25.
Shiels, A.,
Mackay, D.,
Ionides, A.,
Berry, V.,
Moore, A.,
and Bhattacharya, S.
(1998)
Am. J. Hum. Genet.
62,
526-532
26.
Berry, V.,
Mackay, D.,
Khaliq, S.,
Francis, P. J.,
Hameed, A.,
Anwar, K.,
Mehdi, S. Q.,
Newbold, R. J.,
Ionides, A.,
Shiels, A.,
Moore, T.,
and Bhattacharya, S. S.
(1999)
Hum. Genet.
105,
168-170
27.
White, T. W.,
Goodenough, D. A.,
and Paul, D. L.
(1998)
J. Cell Biol.
143,
815-825
28.
Piatigorsky, J.,
Rothschile, S. S.,
and Milstone, L. M.
(1973)
Dev. Biol.
34,
334-345
29.
Menko, A. S.,
Klukas, K. A.,
and Johnson, R. G.
(1984)
Dev. Biol.
103,
129-141
30.
Gu, S.,
Yin, X.,
and Jiang, J. X.
(1999)
Mol. Biol. Cell
10,
405
31.
Jiang, J. X.,
and Goodenough, D. A.
(1998)
Eur. J. Biochem.
255,
37-44
32.
Lin, J. S.,
Fitzgerald, S.,
Dong, Y.,
Knight, C.,
Donaldson, P.,
and Kistler, J.
(1997)
Eur. J. Cell Biol.
73,
141-149
33.
He, D. S.,
Jiang, J. X.,
Taffet, S. M.,
and Burt, J. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6495-6500
34.
White, T. W.,
Bruzzone, R.,
Goodenough, D. A.,
and Paul, D. L.
(1992)
Mol. Biol. Cell
3,
711-720
35.
Jiang, J. X.
(2000)
in
Connexin Methods and Protocols
(Bruzzone, R.
, and Giaume, C., eds)
, pp. 159-174, Humana Press Inc., Totowa, NJ
36.
Jiang, J. X.,
and Goodenough, D. A.
(1998)
Invest. Ophthalmol. Vis. Sci.
39,
537-543
37.
Jiang, J. X.,
and Goodenough, D. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1287-1291
38.
Musil, L. S.,
Beyer, E. C.,
and Goodenough, D. A.
(1990)
J. Membr. Biol.
116,
163-175
39.
Ishizaki, Y.,
Jacobson, M. D.,
and Raff, M. C.
(1998)
J. Cell Biol.
140,
153-158
40.
McGinnis, K. M.,
Wang, K. K. W.,
and Gnegy, M. E.
(1999)
J. Neurochem.
72,
1853-1863
41.
Talanian, R. V.,
Quinlan, C.,
Trautz, S.,
Hackett, M. C.,
Mankovich, J. A.,
Banach, D.,
Ghayur, T.,
Brady, K. D.,
and Wong, W. W.
(1997)
J. Biol. Chem.
272,
9677-9682
42.
Barkett, M.,
Xue, D.,
Horvitz, H. R.,
and Glimore, T. D.
(1997)
J. Biol. Chem.
272,
29419-29422
43.
Walter, J.,
Schindzielorz, A.,
Grünberg, J.,
and Haass, C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1391-1396
44.
Liu, Z. P.,
Galindo, R. L.,
and Wasserman, S. A.
(1997)
Genes Dev.
15,
3413-3422
45.
Rechsteiner, M.,
and Rogers, S. W.
(1996)
Trends Biochem. Sci.
21,
267-271
46.
Lange, C. A.,
Shen, T.,
and Horwitz, K. B.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1032-1037
47.
Le, A. N.,
and Musil, L. S.
(1998)
Dev. Biol.
204,
80-96
48.
Guan, X. J.,
Wilson, S.,
Schlender, K. K.,
and Ruch, R. J.
(1996)
Mol. Carcinog.
16,
157-164
49.
Weil, M.,
Raff, M. C.,
and Braga, M. M.
(1999)
Curr. Biol.
9,
361-364
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. S. Duncan, L. Gyenis, J. Lenehan, M. Bretner, L. M. Graves, T. A. Haystead, and D. W. Litchfield An Unbiased Evaluation of CK2 Inhibitors by Chemoproteomics: Characterization of Inhibitor Effects on CK2 and Identification of Novel Inhibitor Targets Mol. Cell. Proteomics, June 1, 2008; 7(6): 1077 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Roukos, M. S. Iliou, H. Nishitani, M. Gentzel, M. Wilm, S. Taraviras, and Z. Lygerou Geminin Cleavage during Apoptosis by Caspase-3 Alters Its Binding Ability to the SWI/SNF Subunit Brahma J. Biol. Chem., March 30, 2007; 282(13): 9346 - 9357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shibayama, R. Lewandowski, F. Kieken, W. Coombs, S. Shah, P. L. Sorgen, S. M. Taffet, and M. Delmar Identification of a Novel Peptide That Interferes With the Chemical Regulation of Connexin43 Circ. Res., June 9, 2006; 98(11): 1365 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zandy, S. Lakhani, T. Zheng, R. A. Flavell, and S. Bassnett Role of the Executioner Caspases during Lens Development J. Biol. Chem., August 26, 2005; 280(34): 30263 - 30272. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. S. Yu, X. Yin, E. M. Lafer, and J. X. Jiang Developmental Regulation of the Direct Interaction between the Intracellular Loop of Connexin 45.6 and the C Terminus of Major Intrinsic Protein (Aquaporin-0) J. Biol. Chem., June 10, 2005; 280(23): 22081 - 22090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, X. Sun, F. J. Martinez-Wittinghan, X. Gong, T. W. White, and R. T. Mathias Connections Between Connexins, Calcium, and Cataracts in the Lens J. Gen. Physiol., September 27, 2004; 124(4): 289 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M Berthoud, P. J Minogue, J. G Laing, and E. C Beyer Pathways for degradation of connexins and gap junctions Cardiovasc Res, May 1, 2004; 62(2): 256 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. SAEZ, V. M. BERTHOUD, M. C. BRANES, A. D. MARTINEZ, and E. C. BEYER Plasma Membrane Channels Formed by Connexins: Their Regulation and Functions Physiol Rev, October 1, 2003; 83(4): 1359 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pinna Protein kinase CK2: a challenge to canons J. Cell Sci., October 15, 2002; 115(20): 3873 - 3878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moretti, H.-J. Weig, T. Ott, M. Seyfarth, H.-P. Holthoff, D. Grewe, A. Gillitzer, L. Bott-Flugel, A. Schomig, M. Ungerer, et al. Essential myosin light chain as a target for caspase-3 in failing myocardium PNAS, September 3, 2002; 99(18): 11860 - 11865. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||